Patents by Inventor Yoichi Inada

Yoichi Inada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180312566
    Abstract: Provided is an Fc fusion high affinity IgE receptor ?-chain having excellent stability at low pH. An Fc fusion protein comprising: (i) a high affinity IgE receptor ?-chain; and (ii) an Fc region of IgG1, wherein a linker fragment region between the (i) and the (ii) is the amino acid sequence shown in SEQ ID NO: 2.
    Type: Application
    Filed: July 13, 2018
    Publication date: November 1, 2018
    Applicant: Kissei Pharmaceutical Co., Ltd.
    Inventors: Takashi Sakamoto, Yoichi Inada, Kazumasa Yokoyama
  • Patent number: 10077297
    Abstract: Provided is an Fc fusion high affinity IgE receptor ?-chain having excellent stability at low pH. An Fc fusion protein comprising: (i) a high affinity IgE receptor ?-chain; and (ii) an Fc region of IgG1, wherein a linker fragment region between the (i) and the (ii) is the amino acid sequence shown in SEQ ID NO: 2.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: September 18, 2018
    Assignee: Kissei Pharmaceutical Co., Ltd.
    Inventors: Takashi Sakamoto, Yoichi Inada, Kazumasa Yokoyama
  • Patent number: 10047139
    Abstract: Provided is an Fc fusion high affinity IgE receptor ?-chain having excellent stability at low pH. An Fc fusion protein comprising: (i) a high affinity IgE receptor ?-chain; and (ii) an Fc region of IgG1, wherein a linker fragment region between the (i) and the (ii) is the amino acid sequence shown in SEQ ID NO: 2.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: August 14, 2018
    Assignee: Kissei Pharmaceutical Co., Ltd.
    Inventors: Takashi Sakamoto, Yoichi Inada, Kazumasa Yokoyama
  • Publication number: 20180044402
    Abstract: Provided is an Fc fusion high affinity IgE receptor ?-chain having excellent stability at low pH. An Fc fusion protein comprising: (i) a high affinity IgE receptor ?-chain; and (ii) an Fc region of IgG1, wherein a linker fragment region between the (i) and the (ii) is the amino acid sequence shown in SEQ ID NO: 2.
    Type: Application
    Filed: February 19, 2016
    Publication date: February 15, 2018
    Applicant: Kissei Pharmaceutical Co., Ltd.
    Inventors: Takashi Sakamoto, Yoichi INADA, Kazumasa YOKOYAMA
  • Publication number: 20070088088
    Abstract: A method for preventing or treating metabolic syndrome by administering bezafibrate. Since bezafibrate suppresses the action of 11?-hydroxysteroid dehydrogenase type 1 and also accelerates expression of adiponectin receptor, it is used as an agent for preventing or treating metabolic syndrome.
    Type: Application
    Filed: April 19, 2006
    Publication date: April 19, 2007
    Inventors: Yoichi Inada, Shigeru Nakano, Hiroaki Masuzaki